close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,031.13

+0.33%↑

JNJ

195.25

+0.15%↑

ABBV

232.87

-2.25%↓

UNH

323.08

-3.51%↓

AZN

89.04

+0.12%↑

LLY

1,031.13

+0.33%↑

JNJ

195.25

+0.15%↑

ABBV

232.87

-2.25%↓

UNH

323.08

-3.51%↓

AZN

89.04

+0.12%↑

LLY

1,031.13

+0.33%↑

JNJ

195.25

+0.15%↑

ABBV

232.87

-2.25%↓

UNH

323.08

-3.51%↓

AZN

89.04

+0.12%↑

LLY

1,031.13

+0.33%↑

JNJ

195.25

+0.15%↑

ABBV

232.87

-2.25%↓

UNH

323.08

-3.51%↓

AZN

89.04

+0.12%↑

LLY

1,031.13

+0.33%↑

JNJ

195.25

+0.15%↑

ABBV

232.87

-2.25%↓

UNH

323.08

-3.51%↓

AZN

89.04

+0.12%↑

Home・Aandelen Lijst・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Open

SectorGezondheidszorg

2.06 5.1

Buy

Prijsupdate 14 nov 2025, 16:53 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.9300000000000002

Max

2.09

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+308.16% upside

Nieuwssentiment

By Acuity

50%

50%

171 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

1.76 / 1.94 Steun & Weerstand

Inovio Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 nov 2025, 21:34 UTC

Winsten

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

DJ

Lezen

13 nov 2025, 23:45 UTC

Marktinformatie

Nikkei May Fall After Wall Street's Weakness -- Market Talk

DJ

Lezen

13 nov 2025, 23:42 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

DJ

Lezen

13 nov 2025, 23:41 UTC

Marktinformatie

Gold Edges Higher on Possible Dip-Buying -- Market Talk

DJ

Lezen

13 nov 2025, 23:24 UTC

Winsten

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

DJ

Lezen

13 nov 2025, 23:24 UTC

Winsten

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

DJ

Lezen

13 nov 2025, 23:23 UTC

Winsten

JBS NV 3Q EPS 52c >JBS

DJ

Lezen

13 nov 2025, 23:23 UTC

Winsten

JBS NV 3Q Sales $22.6B >JBS

DJ

Lezen

13 nov 2025, 23:04 UTC

Marktinformatie

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

DJ

Lezen

13 nov 2025, 22:02 UTC

Winsten

Nu Holdings 3Q Net $783M >NU

DJ

Lezen

13 nov 2025, 22:01 UTC

Winsten

Nu Holdings 3Q Rev $4.2B >NU

DJ

Lezen

13 nov 2025, 21:51 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

DJ

Lezen

13 nov 2025, 21:50 UTC

Winsten

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

DJ

Lezen

13 nov 2025, 21:45 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

DJ

Lezen

13 nov 2025, 21:41 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

DJ

Lezen

13 nov 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

DJ

Lezen

13 nov 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

DJ

Lezen

13 nov 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

DJ

Lezen

13 nov 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

DJ

Lezen

13 nov 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

DJ

Lezen

13 nov 2025, 21:33 UTC

Marktinformatie

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

DJ

Lezen

13 nov 2025, 21:33 UTC

Winsten

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

DJ

Lezen

13 nov 2025, 21:31 UTC

Winsten

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

DJ

Lezen

13 nov 2025, 21:25 UTC

Winsten

Figure Tech Solutions 3Q Rev $156.4M >FIGR

DJ

Lezen

13 nov 2025, 21:25 UTC

Winsten

Figure Tech Solutions 3Q EPS 34c >FIGR

DJ

Lezen

13 nov 2025, 21:23 UTC

Winsten

Intchains Group 3Q Rev $1.3M >ICG

DJ

Lezen

13 nov 2025, 21:03 UTC

Winsten

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

DJ

Lezen

13 nov 2025, 21:02 UTC

Winsten

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

DJ

Lezen

13 nov 2025, 21:01 UTC

Winsten

Applied Materials 4Q Rev $6.8B >AMAT

DJ

Lezen

13 nov 2025, 21:01 UTC

Winsten

Applied Materials 4Q Gross Margin 48.0% >AMAT

DJ

Lezen

Peer Vergelijking

Prijswijziging

Inovio Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

308.16% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8 USD  308.16%

Hoogste 13 USD

Laagste 3 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Inovio Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Inovio Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

1.76 / 1.94Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

171 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,031.13

↑ +0.33%

JNJ

Johnson and Johnson

195.25

↑ +0.15%

ABBV

AbbVie Inc

232.87

↓-2.25%

UNH

UnitedHealth Group Inc

323.08

↓-3.51%

AZN

AstraZeneca PLC ADR

89.04

↑ +0.12%
help-icon Live chat